Universe Pharmaceuticals Inc.

UPC

$4.08

-5.77%

N/A-$0.25

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Negociación activa

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, ...

Cadena de suministro de UPC

Aguas arriba

Fundiciones, empaquetado, memoria, obleas, componentes y proveedores de insumos.

Aguas arriba

TCM Raw Herb Suppliers (various unlisted Jiangxi/PRC-based trading companies and herb growers)

Pharmaceutical Trading Companies (PRC-based, unnamed in filings)

Herb Farmers and Agricultural Cooperatives (Jiangxi Province and surrounding regions)

Packaging & Labeling Material Suppliers (PRC-based, unnamed)

Kitanihon Pharmaceutical Co., Ltd.

TCM Raw Herb Suppliers (various unlisted Jiangxi/PRC-based trading companies and herb growers)

Suppliers of raw herbal materials for TCMD manufacturing (herbs, roots, extracts for Guben Yanling Pill, Shenrong Weisheng Pill, etc.)

Pharmaceutical Trading Companies (PRC-based, unnamed in filings)

Suppliers of third-party products (biomedical drugs, medical instruments, dietary supplements) for redistribution through Universe Trade

Herb Farmers and Agricultural Cooperatives (Jiangxi Province and surrounding regions)

Tier 2 agricultural suppliers providing raw medicinal herbs to Tier 1 TCM herb traders

Packaging & Labeling Material Suppliers (PRC-based, unnamed)

Suppliers of pharmaceutical packaging, bottles, blister packs, labels for TCMD products

Kitanihon Pharmaceutical Co., Ltd.

Strategic alliance partner for Kampo medicine; potential supplier of Japanese herbal medicine formulations

Aguas abajo

Clientes, distribuidores, OEM y canales que absorben la producción.

Aguas abajo

Pharmaceutical Companies (PRC provincial-level distributors)

Hospitals (primarily in Jiangxi, Jiangsu, Guangdong provinces)

Clinics (primary care and TCM-focused clinics across 30 provinces)

Drugstore Chains (retail pharmacy chains in 30 provinces)

Kitanihon Pharmaceutical Co., Ltd.

Pharmaceutical Companies (PRC provincial-level distributors)

Wholesale customers purchasing TCMD products and third-party products for onward distribution

Hospitals (primarily in Jiangxi, Jiangsu, Guangdong provinces)

Direct end-user customers purchasing TCMD and biomedical products for patient dispensing

Clinics (primary care and TCM-focused clinics across 30 provinces)

End-user customers purchasing chronic condition and cold/flu TCMD treatments

Drugstore Chains (retail pharmacy chains in 30 provinces)

Retail distribution channel for OTC TCMD products and third-party biomedical drugs

Kitanihon Pharmaceutical Co., Ltd.

Strategic alliance (2021) to co-develop and cross-distribute Kampo medicine and high-end TCM products between China and Japan

Comparables

Empresas cotizadas comparables y valores de seguimiento usados como representantes del análisis.

Comparables

China Traditional Chinese Medicine Holdings Co. Limited

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

China Traditional Chinese Medicine Holdings Co. Limited

HKEx:0570

Largest listed pure-play TCM company in China; a Sinopharm subsidiary with comprehensive TCM product portfolio. Serves as a benchmark for the broader TCM sector in which UPC competes.

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

HKEx:3613

Premium TCM brand with 350+ year history; direct competitor in TCM patent medicines for chronic conditions and elderly care. UPC competes in the same TCM derivative segment.

Yunnan Baiyao Group Co., Ltd.

SZSE:000538

Leading Chinese TCM and consumer health company; proxy for TCM industry health and regulatory environment in which UPC operates.

Geografía

Exposiciones regionales que pueden distorsionar la red de suministro.

Geografía

China (PRC) - Jiangxi Province

China (PRC) - 30 provinces

British Virgin Islands

Jiangxi Province hospitals and clinics

PRC pharmaceutical distributors and healthcare institutions (nationwide)

Sununion Holding Group Limited

China (PRC) - Jiangxi Province

Single-country operational concentration; all manufacturing, headquarters, and primary distribution in Jiangxi

Jiangxi Province hospitals and clinicsPrimary end-market in home province

China (PRC) - 30 provinces

Regulatory and policy risk under PRC drug administration (NMPA), pricing controls, and TCM classification changes

PRC pharmaceutical distributors and healthcare institutions (nationwide)Entire downstream network subject to PRC regulatory environment

British Virgin Islands

Parent holding company (Sununion Holding Group Limited) domiciled in BVI; opaque ownership structure; China-VIE related risks

Sununion Holding Group LimitedParent company, BVI-incorporated, controlled by CEO Gang Lai

Concentración

Exposiciones de concentración de clientes, proveedores o socios que pueden distorsionar la red de suministro.

Customer

Medium

No single customer concentration disclosed, but revenue is entirely dependent on PRC domestic market across Jiangxi, Jiangsu, and Guangdong provinces primarily. No international diversification.

Other

Critical

No long-term or continuous supply agreements with any upstream suppliers. All raw material procurement is on an ad-hoc basis, creating supply discontinuity and price volatility risk.

Other

Critical

Extreme revenue decline trajectory: Revenue fell from $40.1M (FY2022) to $32.3M (FY2023) to ~$17.9M (TTM). Net losses and negative operating cash flow indicate potential going-concern risk.

Other

Critical

Micro-cap with ~$2M market cap; Nasdaq listing compliance risk (delayed 20-F filings received staff determination notice in Feb 2025).

Composición de ingresos

Cómo la composición de ingresos se traduce en apalancamiento y dependencia en la cadena de suministro.

TCMD Products (Proprietary) - Chronic Condition Treatments

40.0%

Drives upstream demand for raw herbal materials (ginseng, Chinese yam, medicinal herbs) from TCM herb suppliers. Signature product Guben Yanling Pill is the flagship manufactured SKU.

TCMD Products (Proprietary) - Cold & Flu Medicines

17.6%

Requires similar herbal raw material sourcing as chronic treatments. Seasonal demand pattern affects inventory planning.

Third-Party Products (Biomedical Drugs, Medical Instruments, Dietary Supplements)

42.4%

Distributes products from external pharmaceutical manufacturers. No manufacturing involved; pure distribution/logistics role through subsidiary Universe Trade.

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal